top of page

Combining CT`s efforts with partner(s) and their technologies will create new therapeutic approaches

Our Mission

We promote only the highest quality and most promising candidates for development

We are designing precise and novel cancer therapeutics, drugs which disturb central metabolic steps in cancer cells such as genomic stability and repair mechanisms.

Your Chances with Us

Novel therapeutic class (CT913) with a new mode of action

The success of revolutionizing tumor therapy will be based on Creative Therapeutics’ novel approach in partnership with YOU

In this way by using a unique receptor-mediated targeted therapeutic approach we can avoid introducing unwanted toxicities and side effects to the body.

Our Goal

  • Establishing a partnership with appropriate partners (pharma industries; advanced biotech; investors)

  • Bringing the innovative principle (CT913) to the patient (preclinical rounding off for IND, clinical development (Phase I / Phase II, project transfer to Big Pharma >>> Phase III/Marketing ) at a reasonable time point

Shortterm

Midterm

  • Participating in the increasing project value and appropriate sharing of the revenues

  • Full exploitation of other chemical classes via our platform to design a number of well tolerated compounds with different pharmacological/-dynamic profile for cancer indications.

  • Generation of new IP

  • in the huge market expected with a novel well tolerated therapeutic class (CT913) for cancer treatment having a new mode of action

  • in the establishment of a novel paradigm for cancer treatment  in the future as an alternative to the application of toxic drug regimens 

  • in the realization of a new therapeutic standard leading to the chronification of tumoral disease process by permanently deregulating tumor cell metabolism

goal

We will improve the Quality of Life of cancer patients and providing hope for a cure of their cancers

Participation

<
bottom of page